MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, AVBP has $333,169K in assets. $25,945K in debts. $45,540K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1283.09%
Quick Ratio
1283.09%
Cash Ratio
175.53%
Debt to Asset Ratio
7.79%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Other assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
45,540
Short-term investments
267,281
Prepaid expenses and other current assets
20,076
Total current assets
332,897
Right of use assets - operating leases
13
Deferred offering costs
69
Other assets
190
Total assets
333,169
Accounts payable
5,934
Accrued expenses
19,997
Operating lease liabilities
14
Total current liabilities
25,945
Total liabilities
25,945
Common stock 0.0001 par value, 200,000,000 shares authorized 42,452,251 and 33,706,765 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively
4
Additional paid-in capital
711,847
Accumulated deficit
-404,641
Accumulated other comprehensive income (loss)
14
Total stockholders' equity
307,224
Total liabilities and stockholders' equity
333,169
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$267,281K Cash and cashequivalents$45,540K Prepaid expenses andother current assets$20,076K Total current assets$332,897K Other assets$190K Deferred offering costs$69K Right of use assets -operating leases$13K Total assets$333,169K Total liabilities andstockholders' equity$333,169K Total stockholders'equity$307,224K Total liabilities$25,945K Accumulated deficit-$404,641K Additional paid-in capital$711,847K Total currentliabilities$25,945K Accumulated othercomprehensive income (loss)$14K Common stock 0.0001 parvalue, 200,000,000...$4K Accrued expenses$19,997K Accounts payable$5,934K Operating leaseliabilities$14K

ArriVent BioPharma, Inc. (AVBP)

ArriVent BioPharma, Inc. (AVBP)